The organization argues that designating pharmacists as providers under Medicare Part B would have allowed Congress to dramatically expand COVID-19 testing and immunization efforts.
“The final coronavirus stimulus legislation during this election year presents our shining opportunity to achieve a targeted version of provider status. Together with our members, APhA wants to unleash the full potential of pharmacists’ contributions for testing and immunization during COVID-19,” APhA CEO Scott Knoer, PharmD, said.
APhA created a petition urging Congress to include provider status for pharmacists in its next legislative package.
More articles on pharmacy:
Trump’s meeting with pharma execs canceled after drug lobbies refuse to show up
AstraZeneca to pay Emergent $174M to expand production of COVID-19 vaccine candidate
Generic drug trade group loses bid to block California pay-to-delay law
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.